002653.SZ

Haisco Pharmaceutical Group Co., Ltd. [002653.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

002653.SZ Stock Summary

Earnings have grown 8.73% per last year.

Top 10 Correlated ETFs

002653.SZ

Top 10 Correlated Stocks

002653.SZ

In the News

002653.SZ Financial details

Company Rating

Market Cap

29.64B

Income

489.89M

Revenue

3.3B

Book val./share

Cash/share

Dividend

Dividend %

Employees

4.73K

Optionable

Shortable

Yes

Earnings

18 Apr 2024

P/E

52.81

Forward P/E

PEG

-77.76

P/S

7.81

P/B

6.35

P/C

P/FCF

-315.2

Quick Ratio

1.26

Current Ratio

1.69

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.45

EPS next Y

EPS next Q

EPS this Y

-25%

EPS next Y

EPS next 5Y

EPS last 5Y

3.04%

Revenue last 5Y

-2.53%

Revenue Q/Q

35.95%

EPS Q/Q

164.42%

SMA20

14.07%

SMA50

42.03%

SMA100

18.03%

Inst Own

Inst Trans

ROA

ROE

13%

ROC

0.1%

Gross Margin

72%

Oper. Margin

15%

Profit Margin

15%

Payout

10%

Shs Outstand

Shs Float

Target Price

52W Range

18.59-29.29

52W High

+47.59%

52W Low

+137.78%

RSI

53.35

Rel Volume

0.73

Avg Volume

4.1M

Volume

2.99M

Perf Week

-3.6%

Perf Month

22.25%

Perf Quarter

17.23%

Perf Half Y

19.32%

Beta

-0.06

Volatility

1.1%, 3.38%

Prev Close

-0.23%

Price

42.8

Change

1.42%

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 4.1M
Market Capitalization 29.64B
Employee 4.73K
CEO Ms. Xiu Lian Fan
Headquarters Shannan,CN
IPO Date 2012-01-17
Website https://www.haisco.com

Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.